These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20135693)

  • 1. Release liner removal method for transdermal drug delivery systems (TDDS).
    Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
    J Pharm Sci; 2010 Jul; 99(7):3177-87. PubMed ID: 20135693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating elevated release liner adhesion of a transdermal drug delivery system (TDDS): a study of Daytrana™ methylphenidate transdermal system.
    Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1217-24. PubMed ID: 21438703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations for optimal transdermal drug delivery.
    Durand C; Alhammad A; Willett KC
    Am J Health Syst Pharm; 2012 Jan; 69(2):116-24. PubMed ID: 22215357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesive properties: a critical issue in transdermal patch development.
    Cilurzo F; Gennari CG; Minghetti P
    Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
    Lobo S; Sachdeva S; Goswami T
    Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
    Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
    Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
    Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
    Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for breaking the barriers of drug permeation through transdermal drug delivery.
    Alexander A; Dwivedi S; Ajazuddin ; Giri TK; Saraf S; Saraf S; Tripathi DK
    J Control Release; 2012 Nov; 164(1):26-40. PubMed ID: 23064010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal drug delivery system: patent reviews.
    Samad A; Ullah Z; Alam MI; Wais M; Shams MS
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):143-52. PubMed ID: 19519574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches.
    Mehdizadeh A; Toliate T; Rouini MR; Abashzadeh S; Dorkoosh F
    Acta Pharm; 2004 Dec; 54(4):301-17. PubMed ID: 15634614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transdermal drug delivery systems].
    Foco A; Hadziabdić J; Becić F
    Med Arh; 2004; 58(4):230-4. PubMed ID: 15526592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
    Agrawal SS; Aggarwal A
    Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies.
    Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P
    Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of substrates for 90 degrees peel adhesion--a collaborative study. II. Transdermal drug delivery systems.
    Wokovich AM; Brown SA; Shen M; Doub WH; Cai B; Sadrieh N; Chen ML; Machado S; Buhse LF
    J Biomed Mater Res B Appl Biomater; 2009 Jan; 88(1):61-5. PubMed ID: 18546200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of the Sinomenine transdermal patch.
    Wang J; Ruan J; Zhang C; Ye Y; Cai Y; Wu Y
    Pak J Pharm Sci; 2008 Oct; 21(4):407-10. PubMed ID: 18930863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion testing of polyurethane matrix patches for transdermal delivery of testosterone.
    Dittgen M; Gansen P
    Pharmazie; 2012 Jun; 67(6):567-8. PubMed ID: 22822549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereomicroscopic imaging technique for the quantification of cold flow in drug-in-adhesive type of transdermal drug delivery systems.
    Krishnaiah YS; Katragadda U; Khan MA
    J Pharm Sci; 2014 May; 103(5):1433-42. PubMed ID: 24585397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.